Mentice AB (OSTO:MNTC) Other Financing: kr30.2 Mil (TTM As of Mar. 2026)


OSTO:MNTC Mentice AB OSTO:MNTC
75 GF Score
Price kr13.05
GF Value kr26.01
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Mentice AB Other Financing?

Mentice AB OSTO:MNTC 75 Other Financing is kr30.2 Mil as of Mar. 2026. GuruFocus rates OSTO:MNTC with a GF Score™ of 75/100 and a GF Value™ of kr26.01 (Possible Value Trap). The stock has 2 warning signs investors should review.

Mentice AB's Other Financing for the three months ended in Mar. 2026 was kr0.0 Mil.

Mentice AB's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was kr30.2 Mil.

Mentice AB Other Financing Historical Data

* Premium members only.

The historical data trend for Mentice AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mentice AB Other Financing Chart

Mentice AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only 0.00 -3.50 0.00 0.00 -1.43

Mentice AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 30.20 0.00 0.00
OSTO:MNTC
75GF Score
Mentice AB OSTO:MNTC
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mentice AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr30.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of kr30.2 Mil mean?
Mentice AB (OSTO:MNTC) has a Other Financing of kr30.2 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Mentice AB and its competitors.
Is Mentice AB's Other Financing too high?
Mentice AB's current Other Financing is kr30.2 Mil. Overall, Mentice AB has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mentice AB's Other Financing compare to ABT and SYK?
Mentice AB's Other Financing of kr30.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Mentice AB and its competitors. Mentice AB's current Other Financing is kr30.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mentice AB stock overvalued right now?
Based on GuruFocus' analysis, Mentice AB (OSTO:MNTC) is currently considered Possible Value Trap. The stock's GF Value™ is kr26.01, compared to a current price of kr13.05 — trading 49.8% below its estimated fair value. The current Other Financing is kr30.2 Mil. Mentice AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Mentice AB (OSTO:MNTC), the current Other Financing is kr30.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mentice AB (OSTO:MNTC) Overvalued in 2026?

Based on GuruFocus' analysis, Mentice AB stock appears to be undervalued. The current stock price of kr13.05 is trading 49.8% below its estimated GF Value™ of kr26.01. GuruFocus considers Mentice AB to be Possible Value Trap.

Key valuation signals for OSTO:MNTC:

  • Other Financing: kr30.2 Mil
  • GF Value™: kr26.01 vs. price of kr13.05 (49.8% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the OSTO:MNTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mentice AB Business Description

Other Exchanges MN2:Germany
Address Odinsgatan 10, Gothenburg, SWE, 411 03
Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offering proficiency based simulation solutions that help healthcare professionals acquire, retain, and enhance procedural skills, improving productivity and outcomes. Its solutions are scientifically validated and developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are covered. Mentice operates in two segments: Medical Device Industry (MDI), providing end-to-end solutions supporting development and launch of interventional therapies, and Healthcare Systems (HCS). Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. It operates in EMEA, APAC, and the Americas.
75GF Score

Get the complete analysis for OSTO:MNTC

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr13.05
Price
kr26.01
GF Value